PerkinElmer contributes resources to public cell painting dataset

By The Science Advisory Board staff writers

June 8, 2021 -- PerkinElmer is providing its PhenoVue cell painting kits to the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) consortium to help speed drug discovery.

The consortium, led by the Broad Institute of Massachusetts Institute of Technology and Harvard University, includes pharmaceutical companies and nonprofit research organizations. It is focused on creating and sharing a large public cell imaging dataset to help scientists determine the mechanism of action of new therapeutics in preclinical research stages.

When completed, the dataset will feature information from over 1 billion cells responding to more than 140,000 small molecule and genetic perturbations.

Consortium scientists will use PerkinElmer PhenoVue kits, which provide validated, preoptimized fluorescent probes, to save time and resources.

Copyright © 2021

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.